LP
ENZ

LMR Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

LMR Partners’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,243
Closed -$149K – 416
2017
Q3 		$149K Buy
+14,243
New +$158K 0.02% 287
2015
Q3 		– Sell
-29,224
Closed -$89K – 513
2015
Q2 		$89K Buy
+29,224
New +$82.1K 0.01% 451

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

LMR Partners's ENZ Position: Q4 2017 in Review

LMR Partners sold out of Enzo Biochem, Inc. (ENZ) in Q4 2017, closing a stake of 14,243 shares — an estimated $149K sold.

LMR Partners first reported a position in ENZ in Q2 2015 and held it in 2 quarters. The position peaked at $149K in Q3 2017. 115 funds tracked by Wall St. Rank hold ENZ as of Q4 2017.

  • LMR Partners reported no remaining Enzo Biochem, Inc. position as of Q4 2017 after selling out during the quarter.
  • LMR Partners sold 14,243 Enzo Biochem, Inc. shares in Q4 2017, an estimated $149K.
  • LMR Partners first reported a position in Enzo Biochem, Inc. in Q2 2015 and held it in 2 quarters.
  • LMR Partners's Enzo Biochem, Inc. position peaked at $149K in Q3 2017.
  • 115 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2017.

Based on LMR Partners's 13F filing for Q4 2017, filed 30 Jan 2018.